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Abstract
Parathyroid carcinoma is a rare cause of primary hyperparathyroidism. We detail a 60-years-old gentleman
who was otherwise healthy presented to the hospital due to acute encephalopathy. He was subsequently
found to have parathyroid carcinoma as the cause of the acute encephalopathy with impressive serum
calcium and parathyroid hormone levels. The parathyroid carcinoma was later surgically resected with the
diagnosis confirmed via pathology specimen. The patient was safely discharged from the hospital with
recommendations of close routine outpatient followup. 
Categories: Endocrinology/Diabetes/Metabolism, Internal Medicine, Oncology
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Introduction
Parathyroid carcinoma is a rare cause of primary hyperparathyroidism [1]. It is accountable for less than one
percent of all sporadic primary hyperparathyroidism [2]. According to a systemic review conducted from
1995-2003 by Ruda et al., parathyroid carcinoma accounted for 0.74% of cases out of the total study
population of 22,225 patients [3]. The diagnosis of parathyroid carcinoma is often made status post resection
of the tumor. It is important to recognize parathyroid carcinoma in the early phases as a prompt aggressive
surgical approach is essential for the treatment of the disease [2]. 
Case Presentation
The patient was a 60-years-old gentleman with no pertinent past medical history presented to the
emergency department (ED) due to altered mentation. He was found to be confused, acting strangely in his
home by his neighbor that prompted the urgent ED visit. Initial laboratory findings: temperature 98.1° F,
blood pressure 149/81 mmHg, respiratory rate 26 breaths per minute, heart rate 100 beats per minute, and
oxygen saturation 94% on room air. The patient was alert and oriented to self and unable to follow verbal
commands. Laboratory findings showed a negative urine drug screen, white blood cells of 18.3 K/uL with
neutrophilic predominance along with lactic acid of 3.2 mEq/L, and negative severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Arterial blood gas finding was otherwise unremarkable. The initial
serum calcium was found to be 21.5 mg/dL with parathyroid hormone (PTH) of 1615.1 pg/mL. The
endocrinologist recommended intravenous fluids, calcitonin, cinacalcet, and pamidronate for hypercalcemia
treatment. A computerized tomography (CT) scan of the head was negative for acute intracranial
abnormalities. The chest X-ray was unremarkable for inflammatory processes. There were concerns of sepsis
given acute encephalopathy along with lactic acidosis despite otherwise being hemodynamically stable. He
was subsequently treated empirically with vancomycin, ceftriaxone, ampicillin, obtained cultures, and
admitted into the medical intensive care unit (MICU) for further evaluation. He remained stable overnight. 
On the second day of hospitalization, the patient remained disoriented, confused, and restless in the setting
of hemodynamic stability. The differential diagnosis included meningoencephalitis as nuchal rigidity was
found on physical examination. Lumbar puncture and magnetic resonance imaging of the brain was not
performed as the patient was agitated. Dexamethasone was added to the treatment regimen. The patient
remained in the MICU overnight.
On the third day of hospitalization, he became more agitated on top of confusion and restlessness. The
empirical antibiotics were discontinued as there was a low clinical suspicion of an infectious process given
normalization of lactic acid and negative culture data. Serum calcium level had improved from 21.5 mg/dL to
13.1 mg/dL after receiving the hypercalcemia treatment. PTH continued to trend upwards from 1615.1
pg/mL to 2419.4 pg/mL. There was a strong clinical suspicion that the acute encephalopathy was related to
metabolic derangement due to severe hypercalcemia. He remained hemodynamically stable overnight. 
On days 4-10 of hospitalization, the patient became more lucid as serum calcium level had normalized to
9.1 mg/dL with treatment. CT of the chest, abdomen, and pelvis was ordered as there was a strong concern
for underlying malignancy given the severe hypercalcemia with elevated PTH. CT discovered a 39x33 mm
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mass located at the right retroclavicular location that indented and deviated the trachea to the left side
(Figure 1). No other abnormal masses were discovered in the rest of the imaging study. The paratracheal
mass was subsequently surgically resected and sent for pathology evaluation. 
FIGURE 1: Chest CT scan
A 39x33 mm mass located at the right retroclavicular location that indented and deviated the trachea to the
left side.
On day 11 of hospitalization, the patient recovered well after the surgery with stable hemodynamics,
adequate pain control without surgical complications. His mentation had completely returned to normal as
he was alert and oriented. Postoperative serum calcium level was 7.4 mg/dL with PTH of 277.2 pg/mL. Serum
calcium levels were trended for the next couple of days to ensure there were no signs of hungry bone
syndrome. He was started on calcium carbonate 1250 mg daily. The patient remained to have normal serum
calcium levels with elevated PTH levels for the next few days. There were no physical examination findings
of paresthesias or perioral numbness. Surgical pathology findings revealed parathyroid carcinoma. He was
subsequently discharged with 500 mg of calcium tablets twice a day. He was recommended to have close
follow up in the outpatient setting for the continuation of care. 
Discussion
Acutely altered mentation is one of the common reasons that require hospitalization. An acute cognitive
impairment or delirium is often associated with an underlying illness [4]. There are multiple etiologies that
may contribute to acute delirium. In a prospective study conducted in 229 elderly patients by Francis et al., it
was discovered that common risk factors such as abnormal electrolytes, dementia, fever or hypothermia,
medication side effects, and azotemia were associated with delirium [5]. Our patient, an otherwise healthy
individual with no pertinent medical history, was suddenly found to be delirious by his neighbor. He had
received extensive workup in the medical intensive care unit to rule out potential causes that may explain
his acute encephalopathy. There were initial concerns that his acute delirium could be contributed by an
infectious process as he was treated with empirical broad-spectrum antibiotics. Later on, dexamethasone
was added to his treatment regimen as there was a positive neurological finding of nuchal rigidity to cover
for acute meningoencephalitis. However, these differential diagnoses were soon eliminated, as
hypercalcemia was the cause of the delirium. 
Primary hyperparathyroidism is mostly caused by a solitary benign adenoma (from 80 to 85%). Nevertheless,
other causes include double adenomata (from 2 to 5%), diffuse or nodular hyperplasia (from 10 to 15%), or
parathyroid carcinoma (<1 %) [6]. Severe hypercalcemia is defined as serum calcium > 14 mg/dL. It is often
associated with severe clinical symptoms, including stupor, confusion, lethargy, and coma [7]. The first step
in managing hypercalcemia is to confirm the result of hypercalcemia via total calcium corrected for albumin.
The degree of hypercalcemia could serve as an indicator of the possible underlying etiology once the value is
confirmed. Serum calcium of greater than 13.5 mg/dL is unusual for hyperparathyroidism, whereas it is a
strong suspicion for underlying malignancy [8]. 
Parathyroid carcinoma's important clinical manifestations are related to various factors such as the age,
serum calcium level, and the parathyroid hormone level. According to data obtained from a retrospective
study conducted by Quinn et al. at a tertiary referral center that investigated 3,643 patients who were
referred for surgical evaluation, 18 patients were later found to have papillary carcinoma [9]. Parathyroid
carcinoma patients had larger tumor sizes, higher mean serum calcium and PTH levels, and also had a higher
incidence for hypercalcemic crisis comparing to patients with atypical adenomas. Furthermore, the mean
serum calcium and PTH levels were 13.0 mg/dL and 489 pg/mL, respectively [9]. Interestingly, our patient
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had an impressive initial serum calcium level of 21.5 mg/dL along with PTH level that peaked at 2419.4
pg/mL.
We opted to perform a CT scan of the chest, abdomen, and pelvis as there was a strong suspicion of
malignancy in order to evaluate for anatomical staging as well as pre-operative planning. Based on findings
from a retrospective review of 733 patients with parathyroid carcinoma from the National Cancer Database
from 1985 to 2006 by Asare et al., it was discovered that the age of the patients, tumor size, and sex had an
impact on the five and 10 years overall survival rate of the patients [10]. The primary treatment for
parathyroid carcinoma is surgical resection, as it offers the greatest chance for potential cure [11]. However,
it is advised that the serum calcium levels should be controlled prior to surgery as our patient's
hypercalcemia was normalized after being treated with intravenous fluids, calcitonin, cinacalcet, and
pamidronate. Moreover, adjuvant radiation therapy did not show an absolute survival benefit, whereas other
forms of treatment, including chemotherapy and bio-modifying agents, currently remain unproven and
experimental. Unfortunately, re-operative surgery should be considered if there is a reoccurrence of
malignancy or persistent carcinoma induced hypercalcemia [11]. It was noted that 33% of the patients were
cured after the initial surgical resection, 33% of the patients had a reoccurrence that required reoperation,
and 33% of the patients experienced a short and aggressive clinical course [12]. 
Conclusions
Parathyroid carcinoma is a rare but potentially fatal cause of primary hyperparathyroidism. It is crucial to
have prompt surgical evaluation after initial medical stabilization of the patient that often requires intensive
care unit level of care. Close follow-up is essential as patients could develop complications or reoccurrence
of the malignancy after the initial surgical resection. 
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